Literature DB >> 17117398

Efficacy of cognitive rehabilitation in patients with mild cognitive impairment treated with cholinesterase inhibitors.

Luca Rozzini1, Daniela Costardi, Barbara Vicini Chilovi, Simone Franzoni, Marco Trabucchi, Alessandro Padovani.   

Abstract

BACKGROUND: Individuals who have Mild Cognitive Impairment (MCI) may be in a transitional stage between aging and Alzheimer's disease (AD). The high rate of conversion from MCI to AD makes early treatment an important clinical issue. Recent evidence suggests that cognitive training intervention may reduce the rate of progression to AD.
OBJECTIVES: To evaluate the efficacy of a NeuroPsychological Training (TNP) in patients with MCI who are treated with cholinesterase inhibitors (ChEIs), compared with patients MCI treated only with ChEIs and patients not treated, in a longitudinal, one year follow-up study.
METHODS: One year longitudinal and retrospective comparison study of neuropsychological performances in 59 subjects affected by Mild Cognitive Impairment (MCI) according to Petersen's criteria. Fifteen subjects were randomised to receive TNP plus cholinesterase inhibitors; 22 subjects cholinesterase inhibitors alone and 22 subjects no treatment. All the subjects referring memory complaints, corroborated by an informant, underwent a multidimensional assessment concerning neuropsychological, behavioural and functional characteristics, at baseline and after one year follow-up.
RESULTS: Subjects without treatment maintained their cognitive, functional and behavioural status after one year; patients treated only with ChEIs improved in depressive symptoms whereas subjects treated with TNP and ChEIs showed significant improvements in different cognitive areas, such as memory, abstract reasoning and in behavioural disturbances, particularly depressive symptoms.
CONCLUSIONS: A long-term TNP in ChEIs-treated MCI subjects induces additional cognitive and mood benefits.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17117398     DOI: 10.1002/gps.1681

Source DB:  PubMed          Journal:  Int J Geriatr Psychiatry        ISSN: 0885-6230            Impact factor:   3.485


  56 in total

Review 1.  Cognitive and memory training in adults at risk of dementia: a systematic review.

Authors:  Nicola J Gates; Perminder S Sachdev; Maria A Fiatarone Singh; Michael Valenzuela
Journal:  BMC Geriatr       Date:  2011-09-25       Impact factor: 3.921

Review 2.  Homeostatic disinhibition in the aging brain and Alzheimer's disease.

Authors:  Marc Gleichmann; Vivian W Chow; Mark P Mattson
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

Review 3.  Treatment for mild cognitive impairment: systematic review.

Authors:  Claudia Cooper; Ryan Li; Constantine Lyketsos; Gill Livingston
Journal:  Br J Psychiatry       Date:  2013-09       Impact factor: 9.319

Review 4.  Everyday Impact of Cognitive Interventions in Mild Cognitive Impairment: a Systematic Review and Meta-Analysis.

Authors:  M J Chandler; A C Parks; M Marsiske; L J Rotblatt; G E Smith
Journal:  Neuropsychol Rev       Date:  2016-09-08       Impact factor: 7.444

5.  Improving the quality of life in patients with Alzheimer's disease.

Authors:  Edmund Howe
Journal:  Psychiatry (Edgmont)       Date:  2008-08

6.  Effects of low versus high frequencies of repetitive transcranial magnetic stimulation on cognitive function and cortical excitability in Alzheimer's dementia.

Authors:  Mohamed A Ahmed; Esam S Darwish; Eman M Khedr; Yasser M El Serogy; Anwer M Ali
Journal:  J Neurol       Date:  2011-06-14       Impact factor: 4.849

7.  Communication Difficulty and Relevant Interventions in Mild Cognitive Impairment: Implications for Neuroplasticity.

Authors:  Melissa Johnson; Feng Lin
Journal:  Top Geriatr Rehabil       Date:  2014-01

8.  Memory training interventions for older adults: a meta-analysis.

Authors:  Alden L Gross; Jeanine M Parisi; Adam P Spira; Alexandra M Kueider; Jean Y Ko; Jane S Saczynski; Quincy M Samus; George W Rebok
Journal:  Aging Ment Health       Date:  2012       Impact factor: 3.658

Review 9.  Cognitive intervention programmes on patients affected by Mild Cognitive Impairment: a promising intervention tool for MCI?

Authors:  V Faucounau; Y H Wu; M Boulay; J De Rotrou; A S Rigaud
Journal:  J Nutr Health Aging       Date:  2010-01       Impact factor: 4.075

Review 10.  Phospholipase A2 activation as a therapeutic approach for cognitive enhancement in early-stage Alzheimer disease.

Authors:  Evelin L Schaeffer; Orestes V Forlenza; Wagner F Gattaz
Journal:  Psychopharmacology (Berl)       Date:  2008-10-14       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.